Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

What makes the SAIVE study so good?

Written by | 3 Feb 2023

Professor Colleen Aldous is a research professor at the School of Clinical Medicine at the University of Kwazulu-Natal in South Africa. She recently described the SAIVE trial of… read more.

FDA accepts REGEN-COV for priority review for treatment and prophylaxis of COVID-19 – Regeneron Pharma

Written by | 17 Oct 2021

Regeneron Pharmaceuticals, Inc. has announced that the FDA has accepted for priority review a Biologics License Application (BLA) for REGEN-COV (casirivimab and imdevimab) to treat COVID-19 in non-hospitalized… read more.

Ivermectin gathers pace in Europe

Written by | 31 Jan 2021

Article written by Christine Clark. During the past week Slovakia became the first European country to give formal approval for the use of ivermectin for both prophylaxis and… read more.

Ivermectin meta-analysis – the implications

Written by | 27 Jan 2021

Interview and article by Christine Clark Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, describes the implications of her recently-published meta-analysis of ivermectin trials for covid-19…. read more.

Ivermectin meta-analysis – the background

Written by | 25 Jan 2021

Interview and article by Christine Clark. IMI interviewed Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, to find out more about her recently-published meta-analysis of ivermectin… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.